Ignite Planners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Ignite Planners's VRTX Position: Q2 2026 in Review
Ignite Planners increased its Vertex Pharmaceuticals (VRTX) stake by 85% in Q2 2026, buying an estimated $275K and bringing the position to 1,353 shares worth $673K. The position accounts for 0.09% of the portfolio, ranked #217.
Ignite Planners first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Ignite Planners held 1,353 shares of Vertex Pharmaceuticals worth $673K as of Q2 2026.
- Ignite Planners bought 621 Vertex Pharmaceuticals shares in Q2 2026, an estimated $275K.
- Vertex Pharmaceuticals made up 0.09% of Ignite Planners's portfolio in Q2 2026, its #217 holding.
- Ignite Planners first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Ignite Planners's 13F filing for Q2 2026, filed 23 Jul 2026.